Acute myeloid leukemia: open trials in South Korea

• NCT06788509

  A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

  Trial Treatment · Phase 1 · Janssen Research & Development, LLC

  Severance Hospital, Yonsei University Health System, Seoul

  Registry updated 2026-11-04

• NCT06852222

  A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  Trial Treatment · Phase 3 · Janssen Research & Development, LLC

  Chungnam National University Hospital, Daejeon · National Cancer Center, Goyang-si · Seoul National University Bundang Hospital, Gyeonggi-do · The Catholic University of Korea Seoul St Marys Hospital, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul · Asan Medical Center, Seoul

  Registry updated 2026-11-03

• NCT07155226

  Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

  Trial Treatment · Phase 1/2 · AstraZeneca

  Seoul

  Registry updated 2026-10-23

• NCT07581002

  A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

  Trial Treatment · Phase 2/3 · AbbVie

  Seoul National University Bundang Hospital /ID# 279634, Seongnam-si · Yonsei University Health System - Severance Hospital /ID# 279933, Seoul · Seoul National University Hospital /ID# 279396, Seoul · Samsung Medical Center /ID# 279397, Seoul · Asan Medical Center /ID# 279395, Seoul

  Registry updated 2026-10-22

• NCT07211958

  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  Trial Treatment · Phase 3 · Syndax Pharmaceuticals

  Busan · Daegu · Goyang-si · Seoul

  Registry updated 2026-10-21

• NCT07007312

  Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  Trial Treatment · Phase 3 · Kura Oncology, Inc.

  Pusan National University Hospital, Busan-si · Daegu Catholic University Hospital, Daegu · Chungnam National University Daejeon Hospital, Daejeon · Chonnam National University Hwasun Hospital, Hwasun · Gachon University Gil Medical Center, Namdong · Dong-A University Hospital, Pusan · Anam Hospital Korea University, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Samsung Medical Center, Seoul · Ulsan University Hospital, Ulsan

  Registry updated 2026-10-13

• NCT07306832

  A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

  Trial Treatment · Phase 1 · AbbVie

  Samsung Medical Center /ID# 276979, Seoul · Seoul National University Hospital /ID# 276978, Seoul

  Registry updated 2026-10-05

• NCT06824168

  Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

  Trial Treatment · Phase 2 · Daiichi Sankyo

  Inje University Haeundae Paik Hospital, Busan · Pusan National University Hospital, Busan · Yeungnam University Hospital, Daegu · Kyungpook National University Hospital, Daegu · National Cancer Center, Goyang-si · Gachon University Gil Medical Center, Incheon · jeonbuk National University Hospital, Jeonju · Seoul National University Bundang Hospital, Seongnam · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul · Ajou University Hospital, Suwon · Ulsan University Hospital, Ulsan

  Registry updated 2026-09-16

• NCT04771130

  A Study of BGB-11417 in Participants With Myeloid Malignancies

  Trial Treatment · Phase 1/2 · BeOne Medicines

  Samsung Medical Center, GangnamGu · Severance Hospital Yonsei University Health System, SeodaemunGu

  Registry updated 2026-09-14

• NCT05189639

  A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia

  Research · Pfizer

  Seoul National University Hospital, Seoul

  Registry updated 2026-07-24

• NCT05768932

  BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

  Trial Treatment · Phase 1 · SillaJen, Inc.

  The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Asan Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Korean University Anam Hospital, Seoul · Seoul National University Hospital, Seoul · Samsung Medical Center, Seoul

  Registry updated 2026-06-15

• NCT04988555

  A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.

  Chonnam National University Hwasun Hospital, Hwasun · Seoul National University Hospital, Seoul · Samsung Medical Center, Seoul · The Catholic University of Korea, Seoul

  Registry updated 2026-03-24

• NCT06366789

  Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

  Trial Treatment · Phase 1 · Lomond Therapeutics Holdings, Inc.

  Gachon University Gil Medical Center, Incheon · Korea University Anam Hospital, Seoul · Seoul National University Hospital, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul

  Registry updated 2025-12-31

• NCT03850574

  Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

  Trial Treatment · Phase 1/2 · Aptose Biosciences Inc.

  Kyungpook National University Hospital, Daegu · Pusan National University Hospital, Pusan · Seoul National University Bundang Hospital, Seongnam · Seoul National University Hospital, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul

  Registry updated 2025-08-26

• NCT03507842

  A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.

  Trial Treatment · Phase 3 · Asan Medical Center

  Asan Medical Center, University of Ulsan College of Medicine, Seoul

  Registry updated 2025-03-17

• NCT06073769

  A Post-Marketing Surveillance Study to Assess the Safety of Oral Azacitidine Maintenance Therapy in Korean Patients With Acute Myeloid Leukemia

  Research · Bristol-Myers Squibb

  Novotech Laboratory Korea Co., Ltd., Seoul · Seoul

  Registry updated 2024-11-06

All Acute myeloid leukemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error